$GNPX
Genprex Inc

2017 Form 10-K Financial Statement

#000156459018008342 Filed on April 17, 2018

View on sec.gov

Income Statement

Concept 2017 2016 Q4 2016
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.020M $870.0K $3.780M
YoY Change -20.11% 334.48%
% of Gross Profit
Research & Development $289.9K $130.0K $354.9K
YoY Change -18.3% 77.44%
% of Gross Profit
Depreciation & Amortization $3.242K $0.00 $862.00
YoY Change 276.1%
% of Gross Profit
Operating Expenses $289.9K $1.000M $354.9K
YoY Change -18.3% -66.83%
Operating Profit -$3.312M -$4.132M
YoY Change -19.84%
Interest Expense $1.890K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net -$1.810K $0.00
YoY Change
Pretax Income -$3.310M -$1.000M -$4.130M
YoY Change -19.85% 285.98%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.314M -$1.000M -$4.132M
YoY Change -19.8% 286.18%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$253.8K -$61.09K -$255.1K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2017 2016 Q4 2016
SHORT-TERM ASSETS
Cash & Short-Term Investments $160.0K $1.600M $1.600M
YoY Change -90.0% 595.65%
Cash & Equivalents $1.602M
Short-Term Investments
Other Short-Term Assets $20.00K $40.00K $40.00K
YoY Change -50.0% 100.0%
Inventory
Prepaid Expenses
Receivables $10.00K
Other Receivables $0.00
Total Short-Term Assets $190.0K $1.639M $1.640M
YoY Change -88.41% 556.0%
LONG-TERM ASSETS
Property, Plant & Equipment $10.00K $5.157K $10.00K
YoY Change 0.0%
Goodwill
YoY Change
Intangibles $241.0K
YoY Change
Long-Term Investments
YoY Change
Other Assets $760.0K $266.5K $30.00K
YoY Change 2433.33%
Total Long-Term Assets $1.070M $271.7K $270.0K
YoY Change 296.3% 68.75%
TOTAL ASSETS
Total Short-Term Assets $190.0K $1.639M $1.640M
Total Long-Term Assets $1.070M $271.7K $270.0K
Total Assets $1.260M $1.911M $1.910M
YoY Change -34.03% 365.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $630.0K $290.0K $290.0K
YoY Change 117.24% 1350.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $200.0K $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $830.0K $285.7K $290.0K
YoY Change 186.21% 1350.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $830.0K $285.7K $290.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $830.0K $290.0K $290.0K
YoY Change 186.21% 1350.0%
SHAREHOLDERS EQUITY
Retained Earnings -$14.14M
YoY Change
Common Stock $11.36K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $430.0K $1.625M $1.620M
YoY Change
Total Liabilities & Shareholders Equity $1.260M $1.911M $1.910M
YoY Change -34.03% 365.85%

Cashflow Statement

Concept 2017 2016 Q4 2016
OPERATING ACTIVITIES
Net Income -$3.314M -$1.000M -$4.132M
YoY Change -19.8% 286.18%
Depreciation, Depletion And Amortization $3.242K $0.00 $862.00
YoY Change 276.1%
Cash From Operating Activities -$2.172M -$850.0K -$1.248M
YoY Change 73.97% 80.91%
INVESTING ACTIVITIES
Capital Expenditures $5.889K -$20.00K $4.978K
YoY Change 18.3% -124.89%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$63.42K -$20.00K -$89.53K
YoY Change -29.17% 347.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $794.0K $2.706M
YoY Change -70.66% 275.82%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 794.0K 1.500M 2.706M
YoY Change -70.66% 275.82%
NET CHANGE
Cash From Operating Activities -2.172M -850.0K -1.248M
Cash From Investing Activities -63.42K -20.00K -89.53K
Cash From Financing Activities 794.0K 1.500M 2.706M
Net Change In Cash -1.441M 630.0K 1.368M
YoY Change -205.33% 13580.75%
FREE CASH FLOW
Cash From Operating Activities -$2.172M -$850.0K -$1.248M
Capital Expenditures $5.889K -$20.00K $4.978K
Free Cash Flow -$2.177M -$830.0K -$1.253M
YoY Change 73.75% 87.05%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23479
CY2017 dei Document Period End Date
DocumentPeriodEndDate
2017-12-31
CY2017 dei Entity Registrant Name
EntityRegistrantName
Genprex, Inc.
CY2017 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2018Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13035004
CY2017Q4 us-gaap Cash
Cash
161251
CY2017Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
8844
CY2017Q4 us-gaap Assets Current
AssetsCurrent
193574
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
629074
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
201890
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7804
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
830964
CY2017Q4 gnpx Investment Unit
InvestmentUnit
0
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
11721
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17869205
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17452352
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
428574
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1259538
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11721584
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11721584
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
289934
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3019171
CY2017 dei Document Type
DocumentType
10-K
CY2017 dei Amendment Flag
AmendmentFlag
false
CY2017 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2017 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2017 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2017 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2017 dei Entity Central Index Key
EntityCentralIndexKey
0001595248
CY2016Q4 us-gaap Assets
Assets
1910529
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
285661
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
285661
CY2016Q4 gnpx Investment Unit
InvestmentUnit
0
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
11364
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15751699
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14138195
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
1624868
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1910529
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11364167
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11364167
CY2016 us-gaap Revenues
Revenues
0
CY2017 us-gaap Depreciation
Depreciation
3242
CY2016 us-gaap Depreciation
Depreciation
862
CY2017 us-gaap Revenues
Revenues
0
CY2017 dei Trading Symbol
TradingSymbol
GNPX
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-3312347
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
80
CY2017 us-gaap Interest Expense
InterestExpense
1890
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
671069
CY2016Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
8181
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
28352
CY2017Q2 dei Entity Public Float
EntityPublicFloat
0
CY2016Q4 us-gaap Cash
Cash
1602295
CY2016Q4 us-gaap Assets Current
AssetsCurrent
1638828
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5157
CY2017Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
759591
CY2016Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
25507
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
298569
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
241037
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1058161
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
266544
CY2017Q4 us-gaap Assets
Assets
1259538
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
0
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
354883
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3776414
CY2017 us-gaap Costs And Expenses
CostsAndExpenses
3312347
CY2016 us-gaap Costs And Expenses
CostsAndExpenses
4132159
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-4132159
CY2016 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
CY2016 us-gaap Interest Expense
InterestExpense
0
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1810
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-3314157
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-4132159
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.29
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.38
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11500032
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10834685
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
393737
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2705872
CY2016 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
419450
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2237968
CY2017 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
793971
CY2017 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1095230
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
228662
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
1323892
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
2657418
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
663
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
875
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4873
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
19828
CY2017 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
0
CY2016 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
2519
CY2017 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
734084
CY2016 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
25507
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
545303
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
269307
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2171594
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1248263
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5889
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4978
CY2017 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
57532
CY2016 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
84556
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-63421
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-89534
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
793971
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2705872
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
793971
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2705872
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1441044
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1368075
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1602295
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
234220
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
161251
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.01
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Use of Estimates</font></p> <p style="text-align:justify;margin-top:10pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of our financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.&#160;&#160;Actual results could differ from those estimates.</p></div>
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.76
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.31
CY2017 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
6.6841954
CY2017Q4 gnpx Capital Stock Shares Authorized
CapitalStockSharesAuthorized
210000000
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
0
CY2016Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
1351868
CY2017Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2017 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0
CY2017 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2016 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2017 gnpx Number Of Patents
NumberOfPatents
30
CY2017 gnpx Number Of Pending Patents
NumberOfPendingPatents
2
CY2017Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
4500000
CY2017Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.08
CY2017 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2020-08-13
CY2017 us-gaap Debt Instrument Description
DebtInstrumentDescription
If no event of default occurs prior to August 13, 2020, the Promissory Note and all related interest will be cancelled.
CY2017 gnpx Warrant Right To Purchase Percentage
WarrantRightToPurchasePercentage
0.80
CY2017 gnpx Warrant Discount Rate
WarrantDiscountRate
0.20
CY2017Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.001
CY2014Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.001
CY2014Q1 gnpx Conversion Of Stock Shares Issued And Forward Stock Split
ConversionOfStockSharesIssuedAndForwardStockSplit
1235219
CY2013Q4 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2500000
CY2017 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
207206
CY2017Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
150211
CY2016 gnpx Stock Issued During Period Shares Issued For Services Before Cancellation
StockIssuedDuringPeriodSharesIssuedForServicesBeforeCancellation
133683
CY2016 gnpx Stock Issued During Period Value Issued For Services Before Cancellation
StockIssuedDuringPeriodValueIssuedForServicesBeforeCancellation
469450
CY2016Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
511852
CY2016 gnpx Stock Cancelled During Period Shares Prior To Forward Split Due To Nonperformance Of Services
StockCancelledDuringPeriodSharesPriorToForwardSplitDueToNonperformanceOfServices
1416
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
0.015
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P48M
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2628749
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1957680
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2628749
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.31
CY2017 gnpx Longterm Contract Estimated Cost
LongtermContractEstimatedCost
2000000
CY2017 gnpx Royalty On Sales Percentage
RoyaltyOnSalesPercentage
0.01
CY2017 gnpx Royalty Term
RoyaltyTerm
P21Y
CY2017 gnpx Royalty Payment Annual Minimum
RoyaltyPaymentAnnualMinimum
20000
CY2016Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
176000
CY2017Q4 us-gaap Other Commitment
OtherCommitment
191393
CY2016 us-gaap Legal Fees
LegalFees
15393
CY2016Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
140000
CY2017Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
36000
CY2017Q1 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
120000
CY2017Q1 gnpx Accrued Patent Costs Current
AccruedPatentCostsCurrent
36000
CY2017Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
20000
CY2016 us-gaap Other Expenses
OtherExpenses
36000
CY2017Q2 us-gaap Payments For Royalties
PaymentsForRoyalties
20000
CY2017Q2 us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
240000
CY2017Q2 gnpx Contingent Payments Annual Increase
ContingentPaymentsAnnualIncrease
20000
CY2017Q1 gnpx Contingent Consideration Liability Operating Activities
ContingentConsiderationLiabilityOperatingActivities
240000
CY2017Q1 gnpx Fixed Contingent Consideration Liability Operating Activities
FixedContingentConsiderationLiabilityOperatingActivities
120000
CY2017Q1 us-gaap Finite Lived Intangible Assets Period Increase Decrease
FiniteLivedIntangibleAssetsPeriodIncreaseDecrease
-120000
CY2017Q4 gnpx Percentage Applied On Outstanding Shares For Warrant To Purchase Shares Of Common Stock
PercentageAppliedOnOutstandingSharesForWarrantToPurchaseSharesOfCommonStock
0.03
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.34
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
8000000

Files In Submission

Name View Source Status
0001564590-18-008342-index-headers.html Edgar Link pending
0001564590-18-008342-index.html Edgar Link pending
0001564590-18-008342.txt Edgar Link pending
0001564590-18-008342-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2018041721072872313245.jpg Edgar Link pending
g2018041721072903313246.jpg Edgar Link pending
g2018041721072904013247.jpg Edgar Link pending
g2018041721072905313248.jpg Edgar Link pending
g2018041721072908113249.jpg Edgar Link pending
g2018041721072915013250.jpg Edgar Link pending
g2018041721072916413251.jpg Edgar Link pending
g2018041721072920113252.jpg Edgar Link pending
g2018041721072922413253.jpg Edgar Link pending
g2018041721072946313254.jpg Edgar Link pending
g2018041721072947613255.jpg Edgar Link pending
g2018041721072948813256.jpg Edgar Link pending
g2018041721072950813257.jpg Edgar Link pending
gnpx-10k_20171231.htm Edgar Link pending
gnpx-20171231.xml Edgar Link completed
gnpx-20171231.xsd Edgar Link pending
gnpx-20171231_cal.xml Edgar Link unprocessable
gnpx-20171231_def.xml Edgar Link unprocessable
gnpx-20171231_lab.xml Edgar Link unprocessable
gnpx-20171231_pre.xml Edgar Link unprocessable
gnpx-ex1016_157.htm Edgar Link pending
gnpx-ex1017_156.htm Edgar Link pending
gnpx-ex103_159.htm Edgar Link pending
gnpx-ex104_158.htm Edgar Link pending
gnpx-ex311_155.htm Edgar Link pending
gnpx-ex312_154.htm Edgar Link pending
gnpx-ex321_153.htm Edgar Link pending
gnpx-ex322_152.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending